Advancing pharmacogenetic testing in a tertiary hospital: a retrospective analysis after 10 years of activity
Frontiers in Pharmacology · 19.10.2023 · 14
DOI: 10.3389/fphar.2023.1292416 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 19.10.2023. Verfasst von Stefan Stewart und 12 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacology Department, IdiPAZ, La Paz University Hospital, Madrid, Spain. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The field of pharmacogenetics (PGx) holds great promise in advancing personalized medicine by adapting treatments based on individual genetic profiles. Despite its benefits, there are still economic, ethical and institutional barriers that hinder its implementation in our healthcare environment. A retrospective analysis approach of anonymized data sourced from electronic health records was performed, encompassing a diverse patient population and evaluating key parameters such as prescribing patterns and test results, to assess the impact of pharmacogenetic testing. A head-to-head comparison with previously published activity results within the same pharmacogenetic laboratory was also conducted to contrast the progress made after 10 years. The analysis revealed significant utilization of pharmacogenetic testing in daily clinical practice, with 1,145 pharmacogenetic tests performed over a 1-year period and showing a 35% growth rate increase over time. Of the 17 different medical departments that sought PGx tests, the Oncology department accounted for the highest number, representing 58.47% of all genotyped patients. A total of 1,000 PGx tests were requested for individuals susceptible to receive a dose modification based on genotype, and 76 individuals received a genotype-guided dose adjustment. This study presents a comprehensive descriptive analysis of real-world data obtained from a public tertiary hospital laboratory specialized in pharmacogenetic testing, and presents data that strongly endorse the integration of pharmacogenetic testing into everyday clinical practice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Pharmacology Department, IdiPAZ, La Paz University Hospital, Madrid, Spain.
- Clinical Pharmacology, Hospital Universitario Puerto Real, Cadiz, Spain.
- Pharmacogenetics Laboratory, Genetics Department, La Paz University Hospital, Madrid, Spain.
- Pharmacology Department, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
- Experimental Therapies and Novel Biomarkers in Cancer, Hospital La Paz Institute for Health Research-IdiPAZ, Madrid, Spain.
- Genetics of Metabolic Diseases Laboratory, Genetics Department, La Paz University Hospital, Madrid, Spain.
Zitieren
APA
Stewart, S., Dodero-Anillo, J. M., Guijarro-Eguinoa, J., Arias, P., Gómez López De Las Huertas, A., Seco-Meseguer, E., García-García, I., Ramírez García, E., Rodríguez-Antolín, C., Carcas, A. J., Rodriguez-Novoa, S., Rosas-Alonso, R., & Borobia, A. M. (2023). Advancing pharmacogenetic testing in a tertiary hospital: a retrospective analysis after 10 years of activity. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1292416
Vancouver
Stewart S, Dodero-Anillo JM, Guijarro-Eguinoa J, Arias P, Gómez López De Las Huertas A, Seco-Meseguer E, et al. Advancing pharmacogenetic testing in a tertiary hospital: a retrospective analysis after 10 years of activity. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1292416
BibTeX
@article{Stewart2023,
author = {Stewart, Stefan and Dodero-Anillo, Jose Manuel and Guijarro-Eguinoa, Javier and Arias, Pedro and Gómez López De Las Huertas, Arturo and Seco-Meseguer, Enrique and García-García, Irene and Ramírez García, Elena and Rodríguez-Antolín, Carlos and Carcas, Antonio J and Rodriguez-Novoa, Sonia and Rosas-Alonso, Rocio and Borobia, Alberto M},
title = {Advancing pharmacogenetic testing in a tertiary hospital: a retrospective analysis after 10 years of activity},
journal = {Frontiers in Pharmacology},
year = {2023},
volume = {14},
doi = {10.3389/fphar.2023.1292416}
}
EUVIMED